[go: up one dir, main page]

AU2002213192A1 - A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury - Google Patents

A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury

Info

Publication number
AU2002213192A1
AU2002213192A1 AU2002213192A AU1319202A AU2002213192A1 AU 2002213192 A1 AU2002213192 A1 AU 2002213192A1 AU 2002213192 A AU2002213192 A AU 2002213192A AU 1319202 A AU1319202 A AU 1319202A AU 2002213192 A1 AU2002213192 A1 AU 2002213192A1
Authority
AU
Australia
Prior art keywords
tissue growth
new tissue
vessel injury
blood vessel
patient subjected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213192A
Inventor
A. Michael Lincoff
Steven Marso
Ann-Marie Schmidt
David M. Stern
Eric Topol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of AU2002213192A1 publication Critical patent/AU2002213192A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002213192A 2000-10-13 2001-10-12 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury Abandoned AU2002213192A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68752800A 2000-10-13 2000-10-13
US09/687,528 2000-10-13
US09687528 2000-10-13
PCT/US2001/032036 WO2002030889A2 (en) 2000-10-13 2001-10-12 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury

Publications (1)

Publication Number Publication Date
AU2002213192A1 true AU2002213192A1 (en) 2002-04-22

Family

ID=24760769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213192A Abandoned AU2002213192A1 (en) 2000-10-13 2001-10-12 A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury

Country Status (3)

Country Link
US (2) US7732400B2 (en)
AU (1) AU2002213192A1 (en)
WO (1) WO2002030889A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790443B2 (en) * 1996-11-22 2004-09-14 The Trustees Of Columbia University In The City Of New York Method for treating symptoms of diabetes
US7258857B2 (en) * 1996-11-22 2007-08-21 The Trustees Of Columbia University In The City Of New York Rage-related methods for treating inflammation
US6465422B1 (en) * 1998-04-17 2002-10-15 The Trustees Of Columbia University In The City Of New York Method for inhibiting tumor invasion or spreading in a subject
EP1121454B1 (en) * 1998-10-06 2007-11-14 The Trustees of Columbia University in the City of New York Extracellular novel rage binding protein (en-rage) and uses thereof
WO2004100890A2 (en) 2003-05-09 2004-11-25 The Trustees Of Columbia University In The City Of New York Rage g82s-related methods and compositions for treating inflammatory disorders
WO2005051995A2 (en) * 2003-11-19 2005-06-09 Curagen Corporation Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
EP1771565B1 (en) 2004-07-20 2012-09-05 The Feinstein Institute for Medical Research Rage protein derivatives
US7901688B2 (en) 2004-08-03 2011-03-08 Transtech Pharma, Inc. Rage fusion proteins
US20090060925A1 (en) * 2004-08-03 2009-03-05 The Trustees Of Columbia University In The City Of Rage Fusion Proteins and Methods of Use
EP1869464A4 (en) * 2005-03-17 2009-12-02 Univ Columbia RAGE / DIAPHANE INTERACTION AND ASSOCIATED COMPOSITIONS AND METHODS
US20080207499A1 (en) * 2005-06-29 2008-08-28 Gaetano Barile Rage-related methods for treating and preventing diabetic retinopathy
EP1963786B1 (en) * 2005-12-23 2013-07-24 GCoder Systems AB Positioning pattern
EA015657B1 (en) * 2006-02-09 2011-10-31 Транстек Фарма, Инк. Rage fusion proteins and methods of use
EA017291B1 (en) 2006-05-05 2012-11-30 Транстек Фарма, Инк. Rage fusion proteins, formulations, and methods of use thereof
WO2008100470A2 (en) * 2007-02-15 2008-08-21 Transtech Pharma, Inc. Rage - immunoglobulin fusion proteins
US20100254983A1 (en) * 2007-06-07 2010-10-07 Ann Marie Schmidt Uses of rage antagonists for treating obesity and related diseases
AU2008265983B2 (en) 2007-06-14 2013-06-20 Galactica Pharmaceuticals, Inc. RAGE fusion proteins
EP2421892A1 (en) 2009-04-20 2012-02-29 Pfizer Inc. Control of protein glycosylation and compositions and methods relating thereto
US20110238308A1 (en) 2010-03-26 2011-09-29 Isaac Thomas Miller Pedal navigation using leo signals and body-mounted sensors
US8579927B2 (en) 2011-01-14 2013-11-12 Lemaitre Vascular, Inc. Systems and methods for remote endarterectomy
WO2012170740A2 (en) 2011-06-07 2012-12-13 University Of Hawaii Biomarker of asbestos exposure and mesothelioma
US9561274B2 (en) 2011-06-07 2017-02-07 University Of Hawaii Treatment and prevention of cancer with HMGB1 antagonists
US9360557B1 (en) 2012-07-06 2016-06-07 Apple Inc. Systems, methods, devices and subassemblies for rapid-acquisition access to high-precision positioning, navigation and/or timing solutions
US9618625B2 (en) 2012-07-06 2017-04-11 Apple Inc. System and method for continuous carrier wave reconstruction

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698531A (en) 1989-03-31 1997-12-16 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
NL9301842A (en) 1993-10-25 1995-05-16 Mekka Medical Supplies B V Instrument for releasing and cutting an intima from a blood vessel and a method therefor.
US5790443A (en) * 1994-06-01 1998-08-04 S3 Incorporated Mixed-modulo address generation using shadow segment registers
NL9401633A (en) 1994-10-04 1996-05-01 Surgical Innovations Vof Assembly for the treatment of blood vessels and a method thereof.
WO1997000857A1 (en) 1995-06-21 1997-01-09 Otsuka Kagaku Kabushiki Kaisha Sulfonamide derivatives and insecticide, miticide and nematicide containing the same
US5864018A (en) 1996-04-16 1999-01-26 Schering Aktiengesellschaft Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
AU2696097A (en) 1996-04-16 1997-11-07 Schering Aktiengesellschaft Advanced glycosylation end-product receptor peptides and uses therefor
US5833651A (en) 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US6555651B2 (en) 1997-10-09 2003-04-29 The Trustees Of Columbia University In The City Of New York Ligand binding site of rage and uses thereof
US6790443B2 (en) 1996-11-22 2004-09-14 The Trustees Of Columbia University In The City Of New York Method for treating symptoms of diabetes
US7258857B2 (en) 1996-11-22 2007-08-21 The Trustees Of Columbia University In The City Of New York Rage-related methods for treating inflammation
US7081241B1 (en) 1998-10-06 2006-07-25 The Trustees Of Columbia University In The City Of New York Extracellular rage binding protein (EN-RAGE) and uses thereof
US6125675A (en) * 1997-02-19 2000-10-03 Fastener Engineers Group, Inc. Wire draw machine with integral coil-supporting table
ID23908A (en) 1997-06-05 2000-05-25 Lilly Co Eli TREATMENT METHOD OF TROMBOSIS DISEASE
US7101838B2 (en) 1997-08-05 2006-09-05 The Trustees Of Columbia University In The City Of New York Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
US6465422B1 (en) 1998-04-17 2002-10-15 The Trustees Of Columbia University In The City Of New York Method for inhibiting tumor invasion or spreading in a subject
US6753150B2 (en) 1998-10-05 2004-06-22 The Trustees Of Columbia University In The City Of New York Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
EP1121454B1 (en) 1998-10-06 2007-11-14 The Trustees of Columbia University in the City of New York Extracellular novel rage binding protein (en-rage) and uses thereof
AU5170400A (en) 1999-05-27 2000-12-18 George F. El Khoury Topical application of muscarinic and opioid agents for treatment of tinnitus
EP1307219A4 (en) 1999-08-13 2005-04-06 Univ Columbia PROCESS FOR INHIBITING THE BINDING OF BETA FOLDED FIBRILLES TO RAGE (ADVANCED GLYCATION ENDPRODUCT RECEPTOR)
US6563015B1 (en) 2000-08-14 2003-05-13 The Trustees Of Columbia University In The City Of New York Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
US6825164B1 (en) 2000-08-14 2004-11-30 The Trustees Of Columbia University In The City Of New York Method to increase cerebral blood flow in amyloid angiopathy
US20060140933A1 (en) * 2002-08-16 2006-06-29 Wyeth And Imperial College Innovations Limited Compositions and methods for treating rage-associated disorders
WO2004100890A2 (en) 2003-05-09 2004-11-25 The Trustees Of Columbia University In The City Of New York Rage g82s-related methods and compositions for treating inflammatory disorders
US20090060925A1 (en) 2004-08-03 2009-03-05 The Trustees Of Columbia University In The City Of Rage Fusion Proteins and Methods of Use
US20080207499A1 (en) 2005-06-29 2008-08-28 Gaetano Barile Rage-related methods for treating and preventing diabetic retinopathy

Also Published As

Publication number Publication date
US7732400B2 (en) 2010-06-08
WO2002030889A2 (en) 2002-04-18
WO2002030889A3 (en) 2002-07-11
US8133866B2 (en) 2012-03-13
US20100292134A1 (en) 2010-11-18
US20080171701A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
AU2002213192A1 (en) A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
AU3083301A (en) Improved tissue engineered blood vessels and methods and apparatus for their manufacture
AU5523701A (en) Methods of using growth factors for treating heart disease
AU1179202A (en) Method of cryopreservation of tissues or organs other than a blood vessel by vitrification
AU2001294737A1 (en) Apparatus and method for ablating cardiac tissue
AU2045401A (en) Blood vessel catheter
EP1231976A4 (en) Methods and apparatus for treating body tissues and bodily fluid vessels
AU2001232196A1 (en) A medical instrument for use in cataract surgery and a method for use thereof
AU2002336575A1 (en) Electrosurgical apparatus and methods for tissue treatment and removal
AU3827001A (en) Delivery catheter assembly and method of securing a surgical component to a vessel during a surgical procedure
AU2001294994A1 (en) Cryogenic surgical system and method of use in removal of tissue
AU5843099A (en) Cardiac valve and method for preparing a biological tissue
PL344524A1 (en) Resection device and method of resecting a body tissue
AU2001253493A1 (en) Method and apparatus for coagulation of superficial blood vessels in bladder and proximal urethra
AU6278199A (en) Ultrasonic device for providing reversible tissue damage to heart muscle
AU3507100A (en) Surgical device for suturing tissue
GB9915707D0 (en) Method and apparatus for focused treatment of subcutaneous blood vessels
AU3613300A (en) Method and apparatus for performing minimally invasive surgical procedures
AU2002341876A1 (en) Methods and devices for treating diseased blood vessels
EP0752234A3 (en) An improved skin preparation tray for use in surgical procedures
AU2403600A (en) Apparatus and method for subcutaneous access to the vascular system of a patient
EP1578285A4 (en) A method of treating a stiffened blood vessel
AU2001246467A1 (en) Device and method for endoscopic vascular surgery
AU5101099A (en) Surgical instrument for extracting tissue ingrowth from a permeable member of animplanted catheter
AU6438800A (en) Cannula system for introducing endoscopic tools in a human or animal body